Ultra-Sensitive Multi-Omics Biomarker Detection to transform the future healthcare.
Early is Good has raised $1.6M in total funding. The most recent round was Non-equity Assistance. The last funding was announced in October 2024.
Early is Good's investors include Social Capital.
Early is Good is headquartered in Indianapolis, United States.
Ultra-Sensitive Multi-Omics Biomarker Detection to transform the future healthcare.
Early is Good is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Early is Good — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/early-is-good. Accessed July 19, 2026.
VCBacked. (2024). Early is Good — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/early-is-good
{{cite web |title=Early is Good — Funding & Investors |url=https://www.vcbacked.co/company/early-is-good |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated